![Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases](https://www.frontiersin.org/files/Articles/416881/fendo-09-00625-HTML/image_m/fendo-09-00625-g001.jpg)
Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases
![A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea | NEJM A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1994/nejm_1994.331.issue-14/nejm199410063311403/production/images/img_medium/nejm199410063311403_t3.jpeg)
A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea | NEJM
Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperpro
![Start low, go slowly – mental abnormalities in young prolactinoma patients under cabergoline therapy Start low, go slowly – mental abnormalities in young prolactinoma patients under cabergoline therapy](https://www.degruyter.com/document/doi/10.1515/jpem-2018-0475/asset/graphic/j_jpem-2018-0475_fig_004.jpg)
Start low, go slowly – mental abnormalities in young prolactinoma patients under cabergoline therapy
![Cabergoline monotherapy in the long-term treatment of Cushing's disease in: European Journal of Endocrinology Volume 163 Issue 5 (2010) Cabergoline monotherapy in the long-term treatment of Cushing's disease in: European Journal of Endocrinology Volume 163 Issue 5 (2010)](https://eje.bioscientifica.com/view/journals/eje/163/5/images/large/709fig1.jpeg)
Cabergoline monotherapy in the long-term treatment of Cushing's disease in: European Journal of Endocrinology Volume 163 Issue 5 (2010)
![Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated | SpringerLink Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12020-020-02557-1/MediaObjects/12020_2020_2557_Fig1_HTML.png)
Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated | SpringerLink
![Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study | International Journal of Impotence Research Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study | International Journal of Impotence Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.ijir.3901476/MediaObjects/41443_2006_Article_BF3901476_Fig1_HTML.gif)